Literature DB >> 27852080

Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease.

Ernesto Crisafulli1, Roberta Pisi, Marina Aiello, Matteo Vigna, Panagiota Tzani, Anna Torres, Giuseppina Bertorelli, Alfredo Chetta.   

Abstract

BACKGROUND: In chronic obstructive pulmonary disease (COPD) patients, small-airway dysfunction (SAD) is considered a functional hallmark of disease. However, the exact role of SAD in the clinical presentation of COPD is not yet completely understood; moreover, it is not known whether SAD may have a relationship with the impact of disease.
OBJECTIVES: To evaluate the prevalence of SAD among COPD patients categorized by the old and the new GOLD classification and to ascertain whether there is a relationship between SAD and impact of disease measured by the COPD Assessment Test (CAT) questionnaire.
METHODS: We prospectively enrolled COPD outpatients from the University Hospital of Parma. Using the impulse oscillometry system (IOS), we assessed the fall in resistance from 5 to 20 Hz (R5-R20), reactance at 5 Hz (X5), and resonant frequency (FRes) as markers of peripheral airway dysfunction. According to R5-R20 ≥0.07 or <0.07, the cohort was also categorized in patients with and without SAD, respectively.
RESULTS: We studied 202 patients. In both GOLD classifications, a progressive increasing distribution of R5-R20 and FRes was reported with a decreasing of X5. Moreover, there was a significant correlation between R5-R20 and CAT (r = 0.527, p < 0.001). Finally, the presence of SAD (OR 11.96; 95% CI 4.53-31.58; p < 0.001) and use of ICS + LABA + LAMA (OR 5.31; 95% CI 1.88-15.02; p = 0.002) were independent predictors of higher impact (CAT score ≥10).
CONCLUSION: In COPD patients, the presence of SAD, as assessed by IOS, progressively increases with GOLD classifications and it is closely related to the high impact of disease on health status.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27852080     DOI: 10.1159/000452479

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  23 in total

1.  Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters.

Authors:  Richard Kraemer; Hans-Jürgen Smith; Fabian Gardin; Jürg Barandun; Stefan Minder; Lukas Kern; Martin H Brutsche
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-09-01

2.  Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP.

Authors:  Shunsuke Minagawa; Jun Araya; Naoaki Watanabe; Shota Fujimoto; Junko Watanabe; Hiromichi Hara; Takanori Numata; Kazuyoshi Kuwano; Yoshinori Matsuwaki
Journal:  BMC Pulm Med       Date:  2022-06-28       Impact factor: 3.320

3.  Reference values of impulse oscillometry (IOS) for healthy Chinese children aged 4-17 years.

Authors:  Jinhong Wu; Hao Zhang; Yongsheng Shi; Jinrong Wang; Yuling Han; Qiaoling Zhang; Ning Wang; Sha Liu; Yuehua Zhang; Huifen Zi; Fei Wang; Aihong Liu; Yuxin Song; ChunMei Jia; Yong Feng; Quanhua Liu; Liya Wan; Minghong Ji; Zhen Long; Jianfeng Huang; Li Liu; Yun Sun; Suping Tang; Xiaoyan Dong; Xiaojian Zhou; Wenhui Jiang; Li Shen; Haohua Jiang
Journal:  Respir Res       Date:  2022-07-12

4.  Effects of combination therapy indacaterol/glycopyrronium versus tiotropium on moderate to severe COPD: evaluation of impulse oscillometry and exacerbation rate.

Authors:  Antonio Molino; Francesca Simioli; Anna Agnese Stanziola; Mauro Mormile; Maria Martino; Maria D'Amato
Journal:  Multidiscip Respir Med       Date:  2017-09-27

Review 5.  Day and Night Control of COPD and Role of Pharmacotherapy: A Review.

Authors:  Alberto Braghiroli; Fulvio Braido; Alessio Piraino; Paola Rogliani; Pierachille Santus; Nicola Scichilone
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-04

6.  Assessment of proximal and peripheral airway dysfunction by computed tomography and respiratory impedance in asthma and COPD patients with fixed airflow obstruction.

Authors:  Prapaporn Pornsuriyasak; Thitiporn Suwatanapongched; Wasana Thaipisuttikul; Chayanin Nitiwarangkul; Theerasuk Kawamatawong; Naparat Amornputtisathaporn; Kittipong Maneechotesuwan
Journal:  Ann Thorac Med       Date:  2018 Oct-Dec       Impact factor: 2.219

7.  Abnormalities on Chest Computed Tomography and Lung Function Following an Intense Dust Exposure: A 17-Year Longitudinal Study.

Authors:  Charles Liu; Barbara Putman; Ankura Singh; Rachel Zeig-Owens; Charles B Hall; Theresa Schwartz; Mayris P Webber; Hillel W Cohen; Melissa J Fazzari; David J Prezant; Michael D Weiden
Journal:  Int J Environ Res Public Health       Date:  2019-05-13       Impact factor: 3.390

8.  Lung Function Decline after 24 Weeks of Moxa Smoke Exposure in Rats.

Authors:  Rui He; Li Han; Ping Liu; Hai Hu; Jia Yang; Hong Cai; Chang Huang; Lei Wang; Juntian Liu; Jian Huang; Lue Ha; Yaomeng Liu; Jihong Wu; Maoxiang Zhu; Baixiao Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-10       Impact factor: 2.629

Review 9.  Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Dave Singh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-09-01

Review 10.  Is there room for further innovation in inhaled therapy for airways disease?

Authors:  Martyn F Biddiscombe; Omar S Usmani
Journal:  Breathe (Sheff)       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.